Close

Cantor Lower Price Target on Synergy (SGYP); Maintains Buy

August 12, 2013 10:23 AM EDT Send to a Friend
Cantor Fitzgerald maintained a Buy rating on Synergy Pharmaceuticals (NASDAQ: SGYP) and lowered its price target to $11.00 (from $15.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login